Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ferrante

Showing results (81-90 of 350) with videos related to

Pageof 35
Sort By:
Iscience|April 28, 2022
Integrated analysis of microbe-host interactions in Crohn's disease reveals potential mechanisms of microbial proteins on host gene expressionPadhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, et al.
Therapeutic Drug Monitoring|January 12, 2019
Efficacy, Pharmacokinetics, and Immunogenicity is Not Affected by Switching From Infliximab Originator to a Biosimilar in Pediatric Patients With Inflammatory Bowel DiseaseKaren van Hoeve, Erwin Dreesen, Ilse Hoffman, et al.
Journal of Crohn'S & Colitis|January 6, 2025
Radiation exposure in patients with inflammatory bowel diseaseThibaud Jorissen, Liselotte Fierens, Hilde Bosmans, et al.
BMC Gastroenterology|November 29, 2023
Effectiveness and safety of vedolizumab induction with or without budesonide in patients with moderately to severely active Crohn's disease in Europe: a retrospective observational studyRoni Weisshof, Stephan R Vavricka, Lieven Pouillon, et al.
United European Gastroenterology Journal|December 19, 2024
Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank AnalysisAn Outtier, Rosanne Janssens, Liese Barbier, et al.
International Journal of Colorectal Disease|January 22, 2021
Positioning strictureplasty in the treatment of extensive Crohn's disease ileitis: a comparative study with ileocecal resectionGabriele Bislenghi, Steffen Fieuws, Albert Wolthuis, et al.
Clinical Pharmacokinetics|April 8, 2026
Why the Assay Matters in Model-Informed Precision Dosing: An Example of Ustekinumab in Crohn's DiseaseWei Zhang, Zhigang Wang, Thierry Dervieux, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 20, 2022
Postoperative Crohn's Disease Recurrence: Time to Adapt Endoscopic Recurrence Scores to the Leading Surgical TechniquesPauline Rivière, Gabriele Bislenghi, Séverine Vermeire, et al.
Journal of Crohn'S & Colitis|April 18, 2023
Results of the Eighth Scientific Workshop of ECCO: Diagnosing Postoperative Recurrence of Crohn's Disease After an Ileocolonic Resection With Ileocolonic AnastomosisGabriele Dragoni, Mariangela Allocca, Pär Myrelid, et al.
BMC Health Services Research|December 23, 2025
Multi-stakeholder validation of an evidence-based core set of quality indicators for IBD in BelgiumLiselotte Fierens, Frank E Rademakers, Peter Bossuyt, et al.
Pageof 35

Showing results (81-90 of 350) with videos related to

Sort By:
Pageof 35
Iscience|April 28, 2022
Integrated analysis of microbe-host interactions in Crohn's disease reveals potential mechanisms of microbial proteins on host gene expressionPadhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, et al.
Therapeutic Drug Monitoring|January 12, 2019
Efficacy, Pharmacokinetics, and Immunogenicity is Not Affected by Switching From Infliximab Originator to a Biosimilar in Pediatric Patients With Inflammatory Bowel DiseaseKaren van Hoeve, Erwin Dreesen, Ilse Hoffman, et al.
Journal of Crohn'S & Colitis|January 6, 2025
Radiation exposure in patients with inflammatory bowel diseaseThibaud Jorissen, Liselotte Fierens, Hilde Bosmans, et al.
BMC Gastroenterology|November 29, 2023
Effectiveness and safety of vedolizumab induction with or without budesonide in patients with moderately to severely active Crohn's disease in Europe: a retrospective observational studyRoni Weisshof, Stephan R Vavricka, Lieven Pouillon, et al.
United European Gastroenterology Journal|December 19, 2024
Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank AnalysisAn Outtier, Rosanne Janssens, Liese Barbier, et al.
International Journal of Colorectal Disease|January 22, 2021
Positioning strictureplasty in the treatment of extensive Crohn's disease ileitis: a comparative study with ileocecal resectionGabriele Bislenghi, Steffen Fieuws, Albert Wolthuis, et al.
Clinical Pharmacokinetics|April 8, 2026
Why the Assay Matters in Model-Informed Precision Dosing: An Example of Ustekinumab in Crohn's DiseaseWei Zhang, Zhigang Wang, Thierry Dervieux, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 20, 2022
Postoperative Crohn's Disease Recurrence: Time to Adapt Endoscopic Recurrence Scores to the Leading Surgical TechniquesPauline Rivière, Gabriele Bislenghi, Séverine Vermeire, et al.
Journal of Crohn'S & Colitis|April 18, 2023
Results of the Eighth Scientific Workshop of ECCO: Diagnosing Postoperative Recurrence of Crohn's Disease After an Ileocolonic Resection With Ileocolonic AnastomosisGabriele Dragoni, Mariangela Allocca, Pär Myrelid, et al.
BMC Health Services Research|December 23, 2025
Multi-stakeholder validation of an evidence-based core set of quality indicators for IBD in BelgiumLiselotte Fierens, Frank E Rademakers, Peter Bossuyt, et al.
Pageof 35